EverPoint Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-122,760
Closed -$10.4M 517
2014
Q3
$10.4M Buy
122,760
+39,060
+47% +$3.16M 0.24% 142
2014
Q2
$6.79M Buy
+83,700
New +$6.58M 0.14% 215

Other funds holding NVS

EverPoint Asset Management's NVS Position: Q4 2014 in Review

EverPoint Asset Management sold out of Novartis (NVS) in Q4 2014, closing a stake of 122,760 shares — an estimated $10.4M sold.

EverPoint Asset Management first reported a position in NVS in Q2 2014 and held it in 2 quarters. The position peaked at $10.4M in Q3 2014. 918 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

  • EverPoint Asset Management reported no remaining Novartis position as of Q4 2014 after selling out during the quarter.
  • EverPoint Asset Management sold 122,760 Novartis shares in Q4 2014, an estimated $10.4M.
  • EverPoint Asset Management first reported a position in Novartis in Q2 2014 and held it in 2 quarters.
  • EverPoint Asset Management's Novartis position peaked at $10.4M in Q3 2014.
  • 918 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on EverPoint Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.